Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia
Hattersley, Andrew T.
Journal of the Americal Medical Association (JAMA)
American Medical Association
Copyright 2014 American Medical Association
Glycemic targets in diabetes have been developed to minimize complication risk. Patients with heterozygous, inactivating glucokinase (GCK) mutations have mild fasting hyperglycemia from birth, resulting in an elevated glycated hemoglobin (HbA1c) level that mimics recommended levels for type 1 and type 2 diabetes.
National Institute for Health Research (NIHR)
European Community’s Seventh Framework Programme
This is the author’s version of a work that was accepted for publication in JAMA. Please cite the published version which can be accessed via the DOI in this record.
JAMA, 2014, Vol. 311, Issue 3, pp. 279 - 286
Place of publication